Picture of Lumibird SA logo

LBIRD — Lumibird SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Lumibird Medical Obtains CE Marking For C.Diag, A Platform To Help Diagnose Dry Eye

May 3 (Reuters) - Lumibird SA  LBIRD.PA :
    * LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A
PLATFORM TO
HELP DIAGNOSE DRY EYE
    * THIS EUROPE-WIDE LAUNCH FOLLOWS CE MARKING CERTIFIED BY
LNE-GMED
ON 30 APRIL 2024
    * MARKET ESTIMATED TO BE WORTH $6.4 BILLION IN 2024

Source text for Eikon:  ID:nGNEbQMbF8 
Further company coverage:  LBIRD.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Lumibird SA

See all news